On March 3, 2025, Kent Lake PR LLC, a holder of 6.9% of Quanterix Corporation's outstanding common stock, announced it had nominated three highly qualified, independent candidates for election to the company’s Board of Directors. These nominations are for the 2025 Annual Meeting of Shareholders.
This action by Kent Lake signals its opposition to the company's proposed merger with Akoya Biosciences and its broader concerns regarding Quanterix's strategic direction. The nominations aim to bring new perspectives and accountability to the Board.
The move sets the stage for a potential proxy contest, as Kent Lake seeks to influence the company's governance and strategic decisions, particularly concerning the Akoya merger which it views as not in the best interest of shareholders.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.